Clinical trials
Phase 1 Alzheimer Disease trials in Germany
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
15 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2007 | 2 |
| 2008 | 2 |
| 2009 | 1 |
| 2010 | 1 |
| 2012 | 1 |
| 2015 | 1 |
| 2017 | 2 |
| 2018 | 3 |
| 2020 | 1 |
| 2022 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 12 |
| Terminated | 3 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| GlaxoSmithKline | 4 |
| Janssen Research & Development, LLC | 2 |
| Prof. Dr. Dieter Willbold | 2 |
| Alzeca Biosciences, Inc. | 1 |
| Bristol-Myers Squibb | 1 |
| German Center for Neurodegenerative Diseases (DZNE) | 1 |
| H. Lundbeck A/S | 1 |
| Janssen Pharmaceutica N.V., Belgium | 1 |
| Life Molecular Imaging GmbH | 1 |
| Wyeth is now a wholly owned subsidiary of Pfizer | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Alzheimer Disease | 15 |
| Memory Disorders | 2 |
| Cognition Disorders | 1 |
| Renal Insufficiency | 1 |
| Schizophrenia | 1 |
| Supranuclear Palsy, Progressive | 1 |
Trials
Showing 1 to 15 of 15. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.